Interestingly, it has been indicated that the number of chromosomal breakpoints can be used to predict the outcome of HER2-negative luminal invasive breast carcinomas in the early stages, where breast cancers with 34 breakpoints or less are indicative of good prognosis [50]. This evidence concerns the gene ERBB2 and breast cancer.